期刊文献+

奥拉西坦胶囊联合黛力新或舍曲林治疗老年抑郁伴认知障碍的疗效分析 被引量:3

Effect analysis of olasitan capsule combined with dalixin or shecrin in the treatment of depression and cognitive impairment in the elderly
在线阅读 下载PDF
导出
摘要 目的:探讨老年抑郁伴认知障碍的患者应用奥拉西坦胶囊与黛力新或舍曲林联合治疗的疗效。方法:选择老年抑郁伴认知障碍的患者42例,均采用奥拉西坦胶囊与黛力新或舍曲林方案治疗,观察临床效果。结果:相较治疗前,治疗后老年抑郁伴认知功能障碍患者MoCA评分明显升高,差异有统计学意义(P<0.05)。相较治疗前,治疗后患者日常生活活动能力评分BI明显升高,差异有统计学意义(P<0.05)。相较治疗前,治疗后患者NIHSS评分明显降低,差异有统计学意义(P<0.05)。42例患者经用药治疗,临床控制14例,占33.3%;显效15例,占35.7%;有效12例,占28.6%,无效1例,占2.4%,总有效率为97.6%。本次所选病例仅头晕1例,不良反应率为2.4%,无其他严重不良事件发生。结论:针对临床所选择的老年抑郁伴认知障碍的患者,应用奥拉西坦胶囊与黛力新或舍曲林联合方案治疗,可显著提高日常生活活动能力,改善认知功能,降低神经功能缺损程度,获得理想的治疗效果,且具较高安全性,故具非常重要的应用价值,值得广泛推广。 Objective To investigate the therapeutic effect of olasetam capsule combined with dielexin or shecrin in elderly patients with depression and cognitive impairment.Method 42 cases of elderly patients with depression and cognitive impairment were admitted to our hospital.All patients were treated with olasitam capsule and dalixin or sheculin to observe clinical effects.Results The MoCA score of the elderly patients with depression and cognitive dysfunction was significantly higher after treatment than before treatment.The difference was statistically significant(P<0.05).Compared with before treatment,BI of patients′daily living ability scores increased significantly after treatment,with statistical significance(P<0.05).Compared with before treatment,the NIHSS score of patients after treatment decreased significantly,the difference was statistically significant(P<0.05).Of the 42 patients selected in this group,14 cases(33.3%)were clinically controlled,15 cases(35.7%)were markedly effective,12 cases(28.6%)were effective,1 case(2.4%)was ineffective,and the total effective rate was 97.6%.Only 1 cases of dizziness were selected,the adverse reaction rate was 2.4%,no other serious adverse events occurred.Conclusion Oxiracetam capsule combined with Deanxit or sertraline can significantly improve the activity of daily living,cognitive function,reduce the degree of neurological impairment,and obtain ideal therapeutic effect for senile depression patients with cognitive impairment.Very important application value,it is worth popularizing widely.
作者 廖志东 LIAO Zhi-dong(The First People′s Hospital of Qinzhou,Qinzhou 535000,China)
出处 《吉林医学》 CAS 2019年第12期2787-2788,共2页 Jilin Medical Journal
关键词 老年 抑郁 认知障碍 奥拉西坦胶囊 黛力新 舍曲林 Old age Depression with cognitive impairment Oxiracetam Capsules Deanxit Sertraline
  • 相关文献

参考文献4

二级参考文献53

  • 1贾建平.重视血管性认知障碍的早期诊断和干预[J].中华神经科杂志,2005,38(1):4-6. 被引量:266
  • 2舒凯,席桂发,牛洪泉,董震,于家省,雷霆,李龄.奥拉西坦胶囊治疗颅脑外伤的临床评价[J].中华神经医学杂志,2005,4(5):474-476. 被引量:15
  • 3刘治军,胡欣.促智药奥拉西坦的临床和基础研究[J].中华神经外科疾病研究杂志,2005,4(3):286-288. 被引量:69
  • 4李建纲,张巧俊,高敬龙,袁海峰,骞健,于叔麒,吴仲恒.脑卒中后抑郁患者血5-羟色胺含量的研究[J].中国临床神经科学,2007,15(2):129-132. 被引量:32
  • 5中华医学会神经病学分会痴呆与认知障碍学组写作组.血管性认知障碍诊治指南[J].中华神经科杂志,2011,.
  • 6中华医学会精神科分会主编.中国精神障碍分类与诊断标准第三版[M].济南:山东科学技术出版社,2001.108.
  • 7Elias MF, Sullivan LM, D' Agostino RB, et al. Framingham stroke risk profile and lowered cognitive performance. Stroke, 2004,35 : 404-409.
  • 8Seshadri S, Wolf PA, Beiser A, et al. Stroke risk profile, brain volume,and cognitive function:the Framingham Offspring Study. Neurology ,2004,63 : 1591-1599.
  • 9Pendlebury ST, Rothwell PM. Prevalence, incidence, and factors associated with pre-stroke and poststroke dementia: a systematic review and meta-analysis. Lancet Neuro1,2009,8 : 1006-1018.
  • 10Magot A, Desal H, Wiertlewski S, et al. Dural arteriovenous fistula. A rare cause of treatable dementia. Rev Neurol ( Paris ), 2004, 160:425-433.

共引文献73

同被引文献35

引证文献3

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部